Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma.

Daniele Avenoso,Amal Alabdulwahab,Michelle Kenyon,Varun Mehra,Pramila Krishnamurthy,Francesco Dazzi,Ye Ting Leung,Sandra Anteh,Mili Naresh Shah,Andrea Kuhnl,Robin Sanderson,Piers Patten,Deborah Yallop,Antonio Pagliuca,Victoria Potter

Mediterranean journal of hematology and infectious diseases（2023）

Cited 0|Views21
No score
Abstract
The outcomes of heavily pretreated lymphoma patients are favorable, with median OS and survival not reached after a median of 49 months. In conclusion, even if some lymphoma subgroups cannot be treated (yet) with advanced cellular therapies, this study confirms the role of allo-HSCT as a safe and curative strategy.
More
Translated text
Key words
lymphoma,stem cells,fludarabine-melphalan-campath,peripheral-blood
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined